Availability, and price of anti-hypertensives and antidiabetics in public and private health facilities in Jos, Plateau State and environs North Central Nigeria

https://doi.org/10.51412/psnnjp.2022.35

Authors

  • Dauda Audi Dangiwa Department of Clinical Pharmacy and Pharmacy Practice, University of Jos, Jos https://orcid.org/0000-0002-4658-2785
  • Victory Onize Olutuase Department of Clinical Pharmacy and Pharmacy Practice, University of Benin, Benin City
  • Victor Sunday College of health Sciences, Benue State University
  • Thony Waka Udezi College of health Sciences, Benue State University
  • Nanloh Samuel Jimam Department of Clinical Pharmacy and Pharmacy Practice, University of Jos, Jos
  • Paul Albert Lomak Department of Clinical Pharmacy and Pharmacy Practice, University of Jos, Jos
  • Suwaiba Mohammed Garba Department of Clinical Pharmacy and Pharmacy Practice, University of Jos, Jos
  • Rotkanmwa Charity Okunola Department of Clinical Pharmacy and Pharmacy Practice, University of Jos, Jos
  • Issac Abah Pharmacy Department, Jos University Teaching Hospital, Jos

Keywords:

public and Private centers, availability, price, antidiabetics, hypertensives

Abstract

Background: One of the elements restricting access to medicines is high medicine prices. This can have a detrimental effect on patients' health as well as the healthcare system in terms of lack of patient  compliance with treatment and subsequent hospitalisation for serious complications. The aim of the study is to evaluate the availability and price of antidiabetics and antihypertensives in private and public health centres in Jos and environs.

Method: This study is based on a methodology developed by the World Health Organization (WHO) and HealthAction International (HAI), 2004. It uses a short list of medicines to determine the prices of medicines in different health sectors. Data Analysis was done using the SPSS software. The median price ratio for each drug was calculated as well as the percentage availability.

Results: Most antihypertensives and antidiabetics were sold above the international reference price, median price ratio was above 2.5 for all the drugs surveyed. The mean availability of antihypertensives was 85.43% for generic and 1.59% for branded. In public pharmacies, the mean availability of antihypertensives was 79.45% for generic antihypertensives, and 2.37% for branded antihypertensives.

Conclusion: In both public and private pharmacies availability of Branded antihypertensives and antidiabetics were very low compared to their generic counterparts. The poor availability of essential medicines is likely to be multifactorial, further facilitated by cash-flow constraints, inadequate local manufacturing capacities and resulting import dependencies.

References

The world medicines situation. Geneva, World Health Organization, 2004.

WHO. Price Availability and Affordability: An international comparison of chronic disease medicines, 2005.

World Health Organization; 2003. Prevention of recurrent heart attack s and strokes in low- and middle-income populations: evidence-based recommendations for policymakers and health professionals. Geneva.

World Health organization 2008 Geneva congress. Health Action international. Measuring medicine prices, availability affordability and

price components

Brenda S, Fatima S. Price, availability and affordability of medicines, Afr J Prim Health Care Fam Med. 2014; 6(1): 604.

ZelalemA,Amene T, Segewkal H. (2013) Barriers to access: availability and affordability of essential drugs in a retail outlet of a public health centre in southwestern Ethiopia, Journal of Applied Pharmaceutical Science Vol. 3 (10), pp. 101-105, October, 2013

Said A, Raphael N, Assogba G,3, Said M, Li H, .Ma A. (2015) Medicine pricing: Impact on accessibility and affordability of medicines vis a

vis the product origin as pharmaco-economic drivers in Comoros, Journal of Public Health and Epidemiology. Vol. 7(9), pp. 274-293.

Preventing chronic diseases: a vital investment. Geneva: World Health Organization; 2005.

World health Organization 2008. Health action International. Measuring medicineprices,availability , affordability and

price components 2nd ed.

Kalungia C, Mwale M, Sondashi I. (2017) Availability of Essential Antihypertensive and Antidiabetic Medicines in Public Health Facilities

in Lusaka District, Zambia. Med J Zambia. 44(3):140–8.

Gong S, Cai H, Ding Y, Li W. (2018) The availability, price and affordability of antidiabetic drugs in Hubei province,China. Health Policy

P l a n . 3 3 : 9 3 7 – 4 7 . hƩps://doi.org/10.1093/heapol/czy076

Andrea H, Lindsey H, Birger C, Warren M, Jesper S. (2019) Availability, prices and affordability of Essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia, PLoS ONE 14(12): e0226169.

Aantjes C, Quinian T, Bunders J. (2014) Practicalities and challenges in re-orienting the health system in Zambia for treating chronic

conditions. BMC Health Serv Res. 14:295. hƩps://doi.org/10.1186/1472-6963-14-295 PMID: 25005125.

Brenda S, Suleman F (2014) Price , availability and affordability of medicine, AfrJ Prm Health Care Fam Med. 6(1); 604-610.

Downloads

Published

2022-10-09

How to Cite

Dangiwa, D. A., Olutuase, V. O. ., Sunday, V. ., Udezi, T. W. ., Jimam, N. S. ., Lomak, P. A. ., … Abah, I. . (2022). Availability, and price of anti-hypertensives and antidiabetics in public and private health facilities in Jos, Plateau State and environs North Central Nigeria: https://doi.org/10.51412/psnnjp.2022.35. The Nigerian Journal of Pharmacy, 56(2). Retrieved from https://psnnjp.org/index.php/home/article/view/294

Issue

Vol. 56 No. 2 (2022): Nigerian Journal of Pharmacy

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)